The Discounted Cash Flow (DCF) valuation of AnaptysBio Inc (ANAB) is (47.88) USD. With the latest stock price at 51.00 USD, the upside of AnaptysBio Inc based on DCF is -193.9%.
Based on the latest price of 51.00 USD and our DCF valuation, AnaptysBio Inc (ANAB) is a sell. selling AnaptysBio stocks now will result in a potential gain of 193.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 9.2% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (115.44) - (30.87) | (47.88) |
| Upside | -326.3% - -160.5% | -193.9% |